Evidence map›Paper›PMID 20418072›Full record

Trial reportPsychiatry research2010

Escitalopram attenuates posterior cingulate activity during self-evaluation in healthy volunteers.

Scott C Matthews, Alan N Simmons, Irina A Strigo, Estibaliz Arce, Murray B Stein, Martin P Paulus

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Psychiatry research, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 24 citations in OpenAlex.

  1. Acute Neurofunctional Effects of Escitalopram in Pediatric Anxiety: A Double-Blind, Placebo-Controlled Trial.Journal of the American Academy of Child and Adolescent Psychiatry · 2021
    Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Differential modulation of the default mode network via serotonin-1A receptors.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Scott C MatthewsResearch Service, Veterans Affairs San Diego Healthcare System, San Diego, CA 92161, USA. scmatthews@ucsd.edu
Alan N Simmons
Irina A Strigo
Estibaliz Arce
Murray B Stein
Martin P Paulus
VA San Diego Healthcare System · US

Funding

Fellowship on Biological Psychiatry and NeuroscienceT32MH018399 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Pei-an (Betty) Shih · 1986 to 2026
$7.3M
Neural Substrates of Decision-making in AnxietyR01MH065413 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEIN, MURRAY B. · 2003 to 2011
$2.6M
Improving Patient Outcomes in Anxiety DisordersK24MH064122 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEIN, MURRAY B. · 2001 to 2011
$1.3M
Pharmacological fMRI to Identify New Anxiolytics: A Human BioassayR01MH075792 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI STEIN, MURRAY B. · 2006 to 2008
$1.0M
NIMH NIH HHS 5T32 MH 18399NIMH NIH HHS K24 MH064122NIMH NIH HHS MH 075792NIMH NIH HHS MH 64122NIMH NIH HHS MH 65413NIMH NIH HHS R01 MH065413NIMH NIH HHS R01 MH075792NIMH NIH HHS T32 MH018399
6 · The paper itself

Abstract

Medial cortex is critically involved in self-referential processing. Little is known about how selective serotonin reuptake inhibitors (SSRIs) affect medial cortical activity during self-assessment. We hypothesized that a 3-week oral course of escitalopram,10 mg/day, would alter activity related to self-referential processing in medial cortex. Fifteen healthy females performed a self-assessment task during functional magnetic resonance imaging on two occasions--once after 3 weeks of placebo and once at the end of 3 weeks of escitalopram. Task conditions involved responding "yes" or "no" to whether various positive and negative adjectives described the subject (i.e., "self" evaluation trials) or the subject's best friend (i.e., "other" evaluation trials), whereas the comparison condition involved responding whether the valence of various adjectives was positive or negative (i.e., "word" evaluation trials). Behaviorally after escitalopram, subjects less frequently endorsed that negative adjectives described themselves. Three main neuroimaging results were observed: (1) increased activation in medial prefrontal cortex and posterior cingulate related to self minus word evaluation trials, (2) increased activation in posterior cingulate related to escitalopram minus placebo for self and word evaluation trials, and (3) drug by task interactions in the insula, cerebellum and prefrontal cortex. These results show that SSRIs change medial cortical activity and may alter self-evaluation.

Indexed as

Self-AssessmentAdultBrain MappingCitalopramCross-Over StudiesDouble-Blind MethodFemaleFunctional LateralityGyrus CinguliHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingOxygenSelective Serotonin Reuptake InhibitorsYoung AdultCitalopramOxygenSelective Serotonin Reuptake Inhibitors

Identifiers

PMID20418072
PMCPMC2882791
OpenAlexW2155175423

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.